Integration Profiling Between Plasma Lipidomics, Epstein–Barr Virus and Clinical Phenomes in Nasopharyngeal Carcinoma Patients

• DOI: 10.3389/fmicb.2022.919496
• Publication Date: 2022-06-30T15:43:00Z
• Authors: Yi Huang; Jinfeng Liang; Wenjin Hu; Yushan Liang; Xue Xiao; Weilin Zhao; Xuemin Zhong; Yanping Yang; Xinli Pan; Xiaoying Zhou; Zhe Zhang; Yonglin Cai
• Keywords: Epstein–Barr virus; 03 medical and health sciences; cancer stage; 0302 clinical medicine; LC–MS/MS; nasopharyngeal carcinoma; lipidomics; Microbiology; QR1-502; 3. Good health

Plasma lipidomics has been commonly used for biomarker discovery. Studies in cancer have suggested a significant alteration of circulating metabolite profiles which is correlated with cancer characteristics and treatment outcome. However, the lipidomics characteristics of nasopharyngeal carcinoma (NPC) have rarely been studied. We previously described the phenomenon of lipid droplet accumulation in NPC cells and showed that such accumulation could be regulated by latent infection of Epstein–Barr virus (EBV). Here, we compared the plasma lipidome of NPC patients to that of healthy controls by liquid chromatography-tandem mass spectrometry (LC–MS/MS). We found 19 lipids (e.g., phosphatidylinositols 18:0/20:4 and 18:0/18:2 and free fatty acid 22:6) to be remarkably decreased, whereas 2 lipids (i.e., diacylglycerols 16:0/16:1 and 16:0/20:3) to be increased, in the plasma of NPC patients, compared with controls. Different lipid profiles were also observed between patients with different titers of EBV antibodies (e.g., EA-IgA and VCA-IgA) as well as between patients with and without lymph node or distant organ metastasis. In conclusion, plasma lipidomics might help to differentiate NPC cases from controls, whereas EBV infection might influence the risk and prognosis of NPC through modulating lipid metabolism in both tumor cells and peripheral blood.